FDA Inspection 1123194 — Alabama Center For Reproductive Medicine
The FDA completed an inspection of Alabama Center For Reproductive Medicine on Jan 30, 2020 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 30, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)